A Study to Assess the Safety and Efficacy of Ruxolitinib Cream in Participants With Genital Vitiligo

Condition:   Nonsegmental Vitiligo With Genital Involvement Intervention:   Drug: Ruxolitinib Cream Sponsor:   Incyte Corporation Not yet recruiting

Source: ClinicalTrials.gov - March 2, 2023 Category: Research Source Type: clinical trials